دورية أكاديمية

A Phase II Trial of Personalized Immunotherapy in Patients (pts) with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC) That Have Progressed on Prior Immunotherapy.

التفاصيل البيبلوغرافية
العنوان: A Phase II Trial of Personalized Immunotherapy in Patients (pts) with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC) That Have Progressed on Prior Immunotherapy.
المؤلفون: Zandberg, D.P., Chen, J., Tatsuoka, C., Normolle, D.P., Ohr, J., Isett, B., Rahman, Z., Fenton, M., Gooding, W., Vujanovic, L., Bao, R., Marsh, C., Seastone, D., Gorantla, V., Pabla, S., Conroy, J., Ferris, R.L.
المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e4-e4
قاعدة البيانات: ScienceDirect
الوصف
تدمد:03603016
DOI:10.1016/j.ijrobp.2024.01.019